154 related articles for article (PubMed ID: 26170717)
1. Erratum: BP-C1 in the treatment of patients with stage IV breast cancer: a randomized, double-blind, placebo-controlled multicenter study and an additional open-label treatment phase [Corrigendum].
Breast Cancer (Dove Med Press); 2015; 7():163. PubMed ID: 26170717
[TBL] [Abstract][Full Text] [Related]
2. BP-C1 in the treatment of patients with stage IV breast cancer: a randomized, double-blind, placebo-controlled multicenter study and an additional open-label treatment phase.
Larsen S; Butthongkomvong K; Manikhas A; Trishkina E; Poddubuskaya E; Matrosova M; Srimuninnimit V; Lindkær-Jensen S
Breast Cancer (Dove Med Press); 2014; 6():179-89. PubMed ID: 25473312
[TBL] [Abstract][Full Text] [Related]
3. Erratum: Effects of switching from olanzapine to aripiprazole on the metabolic profiles of patients with schizophrenia and metabolic syndrome: a double-blind, randomized, open-label study [Corrigendum].
Neuropsychiatr Dis Treat; 2015; 11():863. PubMed ID: 25848284
[TBL] [Abstract][Full Text] [Related]
4. Erratum: Morning and evening efficacy evaluation of rupatadine (10 and 20 mg), compared with cetirizine 10 mg in perennial allergic rhinitis: a randomized, double-blind, placebo-controlled trial [Corrigendum].
J Asthma Allergy; 2015; 8():135-7. PubMed ID: 26719714
[TBL] [Abstract][Full Text] [Related]
5. Corrigendum.
Paediatr Child Health; 2015; 20(8):466-7. PubMed ID: 26744561
[TBL] [Abstract][Full Text] [Related]
6. Erratum: User assessment of Norditropin NordiFlex®, a new prefilled growth hormone pen: a Phase IV multicenter prospective study [Corrigendum].
Patient Prefer Adherence; 2013; 7():803. PubMed ID: 23983458
[TBL] [Abstract][Full Text] [Related]
7. Erratum: A Phase II/III, randomized, double-masked, vehicle-controlled, dose-ranging study of the safety and efficacy of OTX-101 in the treatment of dry eye disease [Corrigendum].
Clin Ophthalmol; 2019; 13():215. PubMed ID: 30774301
[TBL] [Abstract][Full Text] [Related]
8. Erratum: A Phase II/III, randomized, double-masked, vehicle-controlled, dose-ranging study of the safety and efficacy of OTX-101 in the treatment of dry eye disease [Corrigendum].
Clin Ophthalmol; 2018; 12():2637. PubMed ID: 30587910
[TBL] [Abstract][Full Text] [Related]
9. Erratum: Onion peel extract reduces the percentage of body fat in overweight and obese subjects: a 12-week, randomized, double-blind, placebo-controlled study.
Park JS; Cha YJ; Lee KH; Yim JE
Nutr Res Pract; 2016 Jun; 10(3):364. PubMed ID: 27231523
[TBL] [Abstract][Full Text] [Related]
10. Erratum: Olmesartan vs ramipril in the treatment of hypertension and associated clinical conditions in the elderly: a reanalysis of two large double-blind, randomized studies at the light of the most recent blood pressure targets recommended by guidelines [Corrigendum].
Clin Interv Aging; 2017; 12():1205. PubMed ID: 28814846
[TBL] [Abstract][Full Text] [Related]
11. Erratum: A Randomized Double-blind Placebo-controlled Trial to Assess the Effect of Tamarind seed in Premature Ejaculation.
Adv Biomed Res; 2018; 7():130. PubMed ID: 30310778
[TBL] [Abstract][Full Text] [Related]
12. Erratum:
Lee YJ; Paik DJ; Kwon DY; Yang HJ; Park Y
Nutr Res Pract; 2017 Dec; 11(6):525. PubMed ID: 29209464
[TBL] [Abstract][Full Text] [Related]
13. Intravenous sotalol for the termination of supraventricular tachycardia and atrial fibrillation and flutter: a multicenter, randomized, double-blind, placebo-controlled study. Sotalol Multicenter Study Group.
Sung RJ; Tan HL; Karagounis L; Hanyok JJ; Falk R; Platia E; Das G; Hardy SA
Am Heart J; 1995 Apr; 129(4):739-48. PubMed ID: 7900626
[TBL] [Abstract][Full Text] [Related]
14. Erratum: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial Assessing Efficacy and Safety of a Novel Low-Dose Turmeric Extract Formulation in Healthy Adults with Chronic Knee Pain [Corrigendum].
Clin Pharmacol; 2023; 15():63-65. PubMed ID: 37397409
[TBL] [Abstract][Full Text] [Related]
15. Erratum: Ocular comfort assessment of lifitegrast ophthalmic solution 5.0% in OPUS-3, a Phase III randomized controlled trial [Corrigendum].
Clin Ophthalmol; 2018; 12():913. PubMed ID: 29845978
[TBL] [Abstract][Full Text] [Related]
16. A randomized, double-blind, placebo-controlled, multicenter, repeat-dose study of two intravenous acetaminophen dosing regimens for the treatment of pain after abdominal laparoscopic surgery.
Wininger SJ; Miller H; Minkowitz HS; Royal MA; Ang RY; Breitmeyer JB; Singla NK
Clin Ther; 2010 Dec; 32(14):2348-69. PubMed ID: 21353105
[TBL] [Abstract][Full Text] [Related]
17. Tamoxifen in Duchenne muscular dystrophy (TAMDMD): study protocol for a multicenter, randomized, placebo-controlled, double-blind phase 3 trial.
Nagy S; Hafner P; Schmidt S; Rubino-Nacht D; Schädelin S; Bieri O; Fischer D
Trials; 2019 Nov; 20(1):637. PubMed ID: 31752977
[TBL] [Abstract][Full Text] [Related]
18. Erratum: Aloe sterol supplementation improves skin elasticity in Japanese men with sunlight-exposed skin: a 12-week double-blind, randomized controlled trial [Corrigendum].
Clin Cosmet Investig Dermatol; 2017; 10():1. PubMed ID: 28031724
[TBL] [Abstract][Full Text] [Related]
19. Erratum: Profile of buparlisib and its potential in the treatment of breast cancer: evidence to date [Corrigendum].
Breast Cancer (Dove Med Press); 2018; 10():51. PubMed ID: 29589598
[TBL] [Abstract][Full Text] [Related]
20. Erratum: Eribulin for the treatment of metastatic breast cancer: an update on its safety and efficacy [Corrigendum].
Int J Womens Health; 2015; 7():403. PubMed ID: 25960676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
